Published in Cancer Weekly, October 16th, 2007
"Initiating the antitumor immune response by creating a tumor antigen supply from dying (apoptotic) tumor cells is a goal of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-10-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.